38 Stocks Moving In Monday's Mid-Day Session

Gainers

  • Reviva Pharmaceuticals Holdings, Inc. RVPH surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms.
  • Proofpoint, Inc. PFPT shares climbed 31.5% to $173.22. Private equity investment firm Thoma Bravo Advantage inked an agreement to acquire cybersecurity and compliance company Proofpoint in an all-cash transaction valuing Proofpoint at $12.3 billion.
  • MicroVision, Inc. MVIS jumped 30% to $23.35 on continued momentum from Friday after investors showed interest in the stock on the r/wallstreetbets group on Reddit. Microvision closed over 36% higher on Friday.
  • Casper Sleep Inc. CSPR shares gained 25.2% to $8.81 after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $10 to $10.50per share.
  • Jiayin Group Inc. JFIN surged 24.7% to $7.16.
  • Ocugen, Inc. OCGN shares rose 23.3% to $11.88. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd., will charge as much as double its main rival AstraZeneca for its vaccines in India.
  • Aeterna Zentaris Inc. AEZS rose 18.1% to $1.1050.
  • Intrusion Inc. INTZ surged 15.1% to $17.87.
  • Puxin Limited NEW gained 15% to $4.3806.
  • Intellicheck, Inc. IDN shares rose 14.8% to $9.70.
  • Treace Medical Concepts, Inc. TMCI gained 13.7% to $29.03. Treace Medical Concepts shares gained 50% on Friday after the company priced its IPO at $17 per share.
  • PHX Minerals Inc. PHX rose 13.5% to $2.5999.
  • Voyager Therapeutics, Inc. VYGR surged 13.4% to $5.30 after the company announced it received FDA clearance of IND application for its gene therapy candidate VY-HTT01 for the treatment of Huntington's disease.
  • Luminar Technologies, Inc. LAZR surged 13.3% to $25.13 after the company announced a partnership deal with Airbus to test autonomous flight technology.
  • ZK International Group Co., Ltd. ZKIN shares rose 13.2% to $6.70 after surging around 10% on Friday.
  • Axsome Therapeutics, Inc. AXSM jumped 13.1% to $59.81 after the company announced FDA acceptance and priority review of its New Drug Application for AXS-05 for the treatment of a major depressive disorder.
  • Scienjoy Holding Corporation SJ gained 13% to $10.95 after the company announced it launched NFTs on its live-streaming platforms.
  • Churchill Capital Corp IV CCIV surged 12.4% to $23.10 as traders circulated April 3 Wccftech article titled 'The Rumor of a Potential Partnership Between Lucid Motors and Apple (AAPL) May Have Some Substance to It After All.'
  • AcelRx Pharmaceuticals, Inc. ACRX rose 12.2% to $1.3808. AcelRx Pharmaceuticals, earlier during the month, announced an investigator-initiated study to assess the perioperative use of Dsuvia (sufentanil sublingual tablet) for same-day surgical procedures in patients on buprenorphine therapy for opioid-use disorder or chronic pain management.
  • Iteris, Inc. ITI gained 12.2% to $7.59.
  • Naked Brand Group Limited NAKD shares rose 11.9% to $0.6378. Naked Brand Group shares gained around 5% on Friday after shareholders vote for approval of the proposed transaction to divest Bendon brick-and-mortar operations.
  • Future FinTech Group Inc. FTFT rose 11.5% to $3.78. Future FinTech Group, last week, inked a preliminary term sheet to acquire money transfer company Khyber Money Exchange Ltd for $0.82 million (€0.69 million).
  • BrainsWay Ltd. BWAY gained 11.1% to $9.16. The FDA has granted 501(k) clearance for BrainsWay’s Theta Burst three-minute protocol utilizing its Deep Transcranial Magnetic Stimulation (Deep TMS) system for major depressive disorder (MDD).
  • AgeX Therapeutics, Inc. AGE rose 10.6% to $1.57. AgeX Therapeutics, earlier during the month, reported a FY20 loss of $0.29 per share.
  • MICT, Inc. MICT rose 9.1% to $1.7999. The company, last month, reported a quarterly loss of $0.14 per share.
  • Vyant Bio, Inc. VYNT rose 8.9% to $3.92. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
  • uniQure N.V. QURE gained 8.8% to $35.13 after the company announced that the FDA removed its Clinical Hold on Hemophilia B Gene therapy program.
  • CASI Pharmaceuticals, Inc. CASI rose 7.1% to $1.80.
  • Sports Entertainment Acquisition Corp. SEAH rose 6.9% to $10.45. Super Group Holding Co is going public with Sports Entertainment Acquisition Corp. The SPAC merger values Super Group Holdings at a pre-money equity valuation of $4.75 billion.
  • W. R. Grace & Co. GRA gained 6.3% to $68.28. Standard Industries Holdings announced plans to acquire W. R. Grace for $70 per share in cash.


Check out these big penny stock gainers and losers

Losers

  • Fortuna Silver Mines Inc. FSM fell 14.5% to $6.59. Fortuna Silver Mines and Roxgold entered into a merger agreement.
  • Sypris Solutions, Inc. SYPR shares fell 13.3% to $3.875 after jumping 59% on Friday.
  • Uxin Limited UXIN fell 12.6% to $1.8801. The company, last week, announced it entered a partnership with JD.com to "launch a self-operated online store for used car transactions through JD's platform."
  • MiMedx Group, Inc. MDXG dropped 9.1% to $10.19.
  • Birks Group Inc. BGI shares fell 8% to $2.3006 after surging over 27% on Friday.
  • Alliance Resource Partners, L.P. ARLP dropped 8% to $6.02 after reporting quarterly financial and operating results.
  • Albertsons Companies, Inc. ACI fell 6.5% to $17.93 after the company issued FY21 EPS guidance below analyst estimates.
  • Koninklijke Philips N.V. PHG fell 4.1% to $58.65 following Q1 results.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!